|
| | Preview | Issue Date | Title | Author(s) |
| 1 | | May-2017 | Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study | Forsyth, Cecily J ; Quach, H.; Fernyhough, L.; Henderson, R.; Corbett, G.; Baker, B.; Browett, P.; Blacklock, H.; Underhill, C.; Cannell, P.; Trotman, J.; Neylon, A.; Harrison, S.; Link, E.; Swern, A.; Cowan, L.; Dimopoulos, M.A.; Miles Prince, H. |
| 2 | | Feb-2020 | Two monogenic disorders masquerading as one: severe congenital neutropenia with monocytosis and non-syndromic sensorineural hearing loss | Forsyth, Cecily J ; Venugopal, P.; Gagliardi, L.; Feng, J.; Phillips, K.; Babic, M.; Poplawski, N.K.; Rienhoff, H.Y.,Jr.; Schreiber, A.W.; Hahn, C.N.; Brown, A.L.; Scott, H.S. |
| 3 | | 1991 | Treatment of acute graft versus host disease with a murine monoclonal antibody to the IL-2 receptor | Tiley, Campbell ; Powles, R.; Teo, C.P.; Treleaven, J.; Findlay, M.; Hewetson, M. |
| 4 | | 5-Jul-2023 | Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variants | Homan, Claire C; Drazer, Michael W; Yu, Kai; Lawrence, David Michael; Feng, Jinghua; Arriola-Martinez, Luis Alberto; Pozsgai, Matthew J; McNeely, Kelsey E; Ha, Thuong Thi; Venugopal, Parvathy; Arts, Peer; King-Smith, Sarah; Cheah, Jesse Jc; Armstrong, Mark; Wang, Paul; Bödör, Csaba; Cantor, Alan B; Cazzola, Mario; Degelman, Erin S; DiNardo, Courtney D; Duployez, Nicolas; Favier, Rémi; Fröhling, Stefan; Rio-Machin, Ana; Klco, Jeffery M; Krämer, Alwin; Kurokawa, Mineo; Lee, Joanne; Malcovati, Luca; Morgan, Neil V; Georges, Natsoulis; Owen, Carolyn; Patel, Keyur P; Preudhomme, Claude; Raslova, Hana; Rienhoff, Hugh Young; Ripperger, Tim; Schulte, Rachael R; Tawana, Kiran; Velloso, Elvira; Benedict, Yan; Kim, Erika Mijin Kwon; Sood, Raman; Hsu, Amy P; Holland, Steven M; Phillips, Kerry; Poplawski, Nicola; Babic, Milena; Wei, Andrew H; Forsyth, Cecily J ; Mar Fan, Helen; Lewis, Ian; Cooney, Julian P; Susman, Rachel; Fox, Lucy C; Blombery, Piers; Singhal, Deepak; Hiwase, Devendra K; Phipson, Belinda; Schreiber, Andreas W; Hahn, Christopher N; Scott, Hamish S; Liu, Paul P; Godley, Lucy A; Brown, Anna L |
| 5 | | May-2017 | Raccoon eyes in systemic light chain amyloidosis | Forsyth, Cecily J ; Tiley, Campbell |
| 6 | | Jul-2021 | Proteasome inhibitor-induced coronary vasospasm in multiple myeloma: A case report | Rogers, James ; Forsyth, Cecily J ; Ford, Tom ; Mikhail, Philopatir |
| 7 | | 14-Jun-2022 | Paraprotein associated heparin resistance during cardiopulmonary bypass | Khuong, Jacqueline N; Forsyth, Cecily J ; Manuel, Lucy; Kingsford-Smith, Kate; Srivastava, Arpit; Bassin, Levi |
| 8 | | 5-Mar-2023 | Painless progressive mononeuritis multiplex secondary to AML associated neuroleukemiosis | Nagaratnam, Sai ; Harinesan, Nimalan; Wijesinghe, Rajiv; Wong-Doo, Nicole; Lyons, Alison ; Morris, Katrina; Triplett, James |
| 9 | | Sep-2019 | Outpatient rituximab, ifosfamide, etoposide (R-IE) in patients older than 60 years with relapsed or refractory diffuse large B-cell lymphoma who are not candidates for stem cell transplantation | Forsyth, Cecily J ; Joshi, M.; Taper, J.; Rowlings, P.; Campbell, P.; Crispin, P.; Harvey, M.; Underhill, C.; Bayley, A.; Byth, K.; Huang, G.; Hertzberg, M. |
| 10 | | Nov-2009 | New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell | Verma, Abhishek K |
| 11 | | Apr-2019 | The natural history of vascular and other complications in patients treated with nilotinib for chronic myeloid leukemia | Forsyth, Cecily J ; Minson, A.G.; Cummins, K.; Fox, L.; Costello, B.; Yeung, D.; Cleary, R.; Tatarczuch, M.; Burbury, K.; Motorna, O.; Shortt, J.; Fleming, S.; McQuillan, A.; Schwarer, A.; Harrup, R.; Holmes, A.; Ratnasingam, S.; Chan, K.L.; Hsu, W.H.; Ashraf, A.; Putt, F.; Grigg, A. |
| 12 | | Dec-2019 | A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons | Tiley, Campbell ; Stevenson, W.; Bryant, J.; Watson, R.; Sanson-Fisher, R.; Oldmeadow, C.; Henskens, F.; Brown, C.; Ramanathan, S.; Enjeti, A.; Guest, J.; Tzelepis, F.; Paul, C.; D'Este, C. |
| 13 | | Oct-2021 | An MRD-stratified pediatric protocol is as deliverable in adolescents and young adults as children with ALL | Wylie, Brenton ; Greenwood, M.; Trahair, T.; Sutton, R.; Osborn, M.P.; Kwan, J.; Mapp, S.; Howman, R.; Anazodo, A.; D'Rozario, J.; Hertzberg, M.; Irving, I.; Yeung, D.T.; Coyle, L.; Jager, A.; Engeler, D.M.; Venn, N.C.; Frampton, C.; Wei, A.H.; Bradstock, K.F.; Dalla-Pozza, L. |
| 14 | | 29-Jun-2022 | Monoclonal B-cell Lymphocytosis - a review of diagnostic criteria, biology, natural history, and clinical management | Tang, Catherine ; Shen, Yandong; Soosapilla, Asha; Mulligan, Stephen P |
| 15 | | Sep-2020 | Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamics | Tiley, Campbell ; Nath, C.E.; Trotman, J.; Nivison-Smith, I.; Gurney, H.; Zeng, L.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; McLachlan, Andrew ; Shaw, P.J. |
| 16 | | Oct-2016 | Localized axillary milia en plaque: a rare cutaneous case presentation of systemic amyloidosis | Wylie, Brenton ; Dickison, P.; Howard, V.; Smith, Saxon D |
| 17 | | Jan-2020 | Intensive chemotherapy and up-front stem cell transplant for double hit lymphoma | Armytage, Tasman ; Othman, J.; Wong, K.; Arthur, C.; Fay, K.; Stevenson, W.; MacKinlay, N.; Ward, C.; Pechey, V.; Coyle, L.; Kerridge, Ian ; Greenwood, M. |
| 18 | | May-2017 | The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia | Forsyth, Cecily J ; Fox, L.; Cummins, K.D.; Costello, B.; Yeung, D.; Cleary, R.; Tatarczuch, M.; Burbury, K.; Motorna, O.; Shortt, J.; Fleming, S.; McQuillan, A.; Schwarer, A.; Harrup, R.; Holmes, A.; Ratnasingam, S.; Chan, K.L.; Hsu, W.H.; Ashraf, A.; Putt, F.; Grigg, A. |
| 19 | | Jun-2023 | Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility | Mills, Georgia S; Chadwick, Verity; Tang, Catherine ; Perram, Jacinta; Anderson, Mary Ann; Anazodo, Antoinette; Kidson-Gerber, Giselle; Shand, Antonia; Lavee, Orly; Withers, Barbara; Milliken, Sam; Di Ciaccio, Pietro R; Hamad, Nada |
| 20 | | May-2017 | Idarubicin dose escalation during consolidation therapy for adult Acute Myeloid Leukemia | Tiley, Campbell ; Bradstock, K.F.; Link, E.; Di Iulio, J.; Szer, J.; Marlton, P.; Wei, A.H.; Enno, A.; Schwarer, A.; Lewis, I.D.; D'Rozario, J.; Coyle, L.; Cull, G.; Campbell, P.; Leahy, M.F.; Hahn, U.; Cannell, P.; Lowenthal, R.M.; Moore, J.; Cartwright, K.; Cunningham, I.; Taper, J.; Grigg, A.; Roberts, A.W.; Benson, W.; Hertzberg, M.; Deveridge, S.; Rowlings, P.; Mills, A.K.; Gill, Devinder S ; Bardy, P.; Campbell, L.J.; Seymour, J.F. |
| 21 | | Aug-2018 | Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk Features | Forsyth, Cecily J ; Godfrey, A.L.; Campbell, P.J.; MacLean, C.; Buck, G.; Cook, J.; Temple, J.; Wilkins, B.S.; Wheatley, K.; Nangalia, J.; Grinfeld, J.; McMullin, M.F.; Kiladjian, J.J.; Green, A.R.; Harrison, C.N. |
| 22 | | Apr-2018 | Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic Leukaemia | Forsyth, Cecily J ; Crassini, K.R.; Zhang, E.; Balendran, S.; Freeman, J.A.; Best, O.G.; Mackinlay, N.J.; Han, P.; Stevenson, W.S.; Mulligan, S.P. |
| 23 | | Jul-2016 | High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation | Tiley, Campbell ; Nath, C.E.; Trotman, J.; Presgrave, P.; Joshua, D.; Kerridge, Ian ; Kwan, Y.L.; Gurney, H.; McLachlan, Andrew ; Earl, J.W.; Nivison-Smith, I.; Zeng, L.; Shaw, P.J. |
| 24 | | Jan-2019 | Hereditary haemorrhagic telangiectasia | Forsyth, Cecily J ; Mangkorntongsakul, Varitsara |
| 25 | | Oct-2020 | Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product | Forsyth, Cecily J ; Niederwieser, D.; Hamm, C.; Cobb, P.; Mo, M.; Tucci, A.; Hanes, V.; Delwail, V.; Hajek, R.; Chien, D. |
| 26 | | Apr-2009 | The direct factor Xa inhibitor rivaroxaban | Verma, Abhishek K |
| 27 | | 16-Sep-2021 | Diffuse large B-cell lymphoma: A consensus practice statement from the Australasian Lymphoma Alliance | Armytage, Tasman ; Wight, J.; Hamad, N.; Campbell, B. A.; Ku, M.; Lee, K.; Rose, H.; Latimer, M.; Lee, H. P.; Lee, S. T.; Dickinson, M.; Khor, R.; Verner, E. |
| 28 | | Jan-2023 | Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control study | Odutola, Michael K; van Leeuwen, Marina T; Bassett, Julie K; Bruinsma, Fiona; Turner, Jennifer; Seymour, John F; Prince, Henry Miles; Milliken, Samuel T; Hertzberg, Mark; Roncolato, Fernando; Opat, Stephen S; Lindeman, Robert; Tiley, Campbell ; Trotman, Judith; Verner, Emma; Harvey, Michael; Underhill, Craig R; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 29 | | Jan-2018 | Delayed-onset heparin-induced thrombocytopenia complicated by arterial and venous thromboses | Forsyth, Cecily J ; Harrison; Balendran, S.; Harrison, A.; Morel-Kopp, M. C.; Ward, C. |
| 30 | | Dec-2018 | The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complications | Forsyth, Cecily J ; Melville, K.; Tiley, Campbell |
| 31 | | Apr-2020 | Cutaneous multiple myeloma | Forsyth, Cecily J ; Jagger, Jacqueline ; Lai, S. |
| 32 | | May-2021 | COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement | Armytage, Tasman ; McCaughan, G.; Di Ciaccio, P.; Ananda-Rajah, M.; Gilroy, N.; MacIntyre, R.; Teh, B.; Weinkove, R.; Curnow, J.; Szer, J.; Enjeti, A.K.; Ross, D.M.; Mulligan, S.; Trotman, J.; Dickinson, M.; Quach, H.; Choi, P.; Polizzotto, M.N.; Tam, C.S.; Ho, P.J.; Ku, M.; Gregory, G.; Gangatharan, S.; Hapgood, G.; Cochrane, T.; Cheah, C.; Gibbs, S.; Wei, A.; Johnston, A.; Greenwood, M.; Prince, H.M.; Latimer, M.; Berkahn, L.; Wight, J.; Hamad, N. |
| 33 | | Aug-2016 | Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort | Forsyth, Cecily J ; Campbell, P.J.; MacLean, C.; Beer, P.A.; Buck, G.; Wheatley, K.; Kiladjian, J.J.; Harrison, C.N.; Green, A.R. |
| 34 | | Feb-2017 | Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory. | Forsyth, Cecily J ; Agarwal, R.; Blombery, P.; McBean, M.; Jones, K.; Fellowes, A.; Doig, K.; Westerman, D.A. |
| 35 | | 7-Mar-2023 | The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance | Di Ciaccio, Pietro R; Mills, Georgia; Shipton, Michael J; Campbell, Belinda; Gregory, Gareth; Langfield, Jenna; Greenwood, Matthew; McKeague, Sean; Shanavas, Mohammad; Eslick, Renee; Kidson-Gerber, Giselle; Smallbone, Portia; Tang, Catherine ; Morris, Kirk; Bilmon, Ian; Yannakou, Costas; Badoux, Xavier; Berkahn, Leanne; Farina, Sergio; Mason, Kylie D; Motum, Penelope; Goss, Kathryn; Hamad, Nada |
| 36 | | 20-Dec-2022 | Clinical characteristics of Australian treatment-naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry | Nguyen, James; Wellard, Cameron; Chung, Eliza; Cheah, Chan Y; Dickinson, Michael; Doo, Nicole Wong; Keane, Colm; Talaulikar, Dipti; Berkahn, Leanne; Morgan, Susan; Hamad, Nada; Cochrane, Tara; Johnston, Anna M; Forsyth, Cecily J ; Opat, Stephen; Barraclough, Allison; Mutsando, Howard; Ratnasingam, Sumita; Giri, Pratyush; Wood, Erica M; McQuilten, Zoe K; Hawkes, Eliza A |
| 37 | | Apr-2019 | Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014 | Forsyth, Cecily J ; Baade, P.D.; Ross, D.M.; Anderson, L.A.; Fritschi, L. |
| 38 | | 7-Oct-2022 | Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma | Nath, Christa Ellen; Grigg, Andrew; Rosser, Sebastian P A; Estell, Jane; Newman, Elizabeth; Tiley, Campbell ; Ramanathan, Sundra; Ho, Shir Jing; Larsen, Stephen; Gibson, John; Presgrave, Peter ; Shaw, Peter John; Trotman, Judith |
| 39 | | Mar-2017 | A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosis | Forsyth, Cecily J ; Ho, P.J.; Bajel, A.; Burbury, K.; Dunlop, L.; Durrant, S.; Perkins, A.C.; Ross, D.M. |
| 40 | | 24-Nov-2022 | Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study | Mills, Georgia S; Di Ciaccio, Pietro R; Tang, Catherine ; Chadwick, Verity; Mason, Kylie D; Campbell, Belinda A; Shipton, Michael J; Shanavas, Mohamed; Morris, Kirk L; Greenwood, Matthew; Langfield, Jenna; Kidson-Gerber, Giselle; Eslick, Renee; Badoux, Xavier; Yannakou, Costas K; Gangatharan, Shane A; Bilmon, Ian; Hamad, Nada |
| 41 | | Jan-2017 | Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea | Forsyth, Cecily J ; Douglas, G.; Harrison, C.N.; Bennett, M.; Stevenson, W.S.; Hounsell, J.; Ratnasingam, S.; Ritchie, D.; Ross, D.M.; Grigg, A. |
| 42 | | Feb-2023 | Australian experience with ibrutinib in patients with relapsed/refractory mantle cell lymphoma: a study from the Lymphoma and Related Diseases Registry | Baggio, Diva; Wellard, Cameron; Chung, Eliza; Talaulikar, Dipti; Keane, Colm; Opat, Stephen; Giri, Pratyush; Minson, Adrian; Cheah, Chan Yoon; Armytage, Tasman ; Lee, Denise; Chong, Geoffrey; Johnston, Anna; Cochrane, Tara; Waters, Neil; Hamad, Nada; Wood, Erica M; Hawkes, Eliza A |
| 43 | | May-2020 | Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic | Armytage, Tasman ; Di Ciaccio, P.; McCaughan, G.; Trotman, J.; Ho, P.J.; Cheah, C.Y.; Gangatharan, S.; Wight, J.; Ku, M.; Quach, H.; Gasiorowski, R.; Polizzotto, M.N.; Prince, H.M.; Mulligan, S.; Tam, C.S.; Gregory, G.; Hapgood, G.; Spencer, A.; Dickinson, M.; Latimer, M.; Johnston, A.; Lee, C.; Cochrane, T.; Berkahn, L.; Weinkove, R.; Doocey, R.; Harrison, H.J.; Webber, N.; Lee, H.P.; Chapman, S.; Campbell, B.A.; Gibbs, S.D.J.; Hamad, N. |
| 44 | | Aug-2021 | Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement | Tiley, Campbell ; Hamad, N.; Ananda-Rajah, M.; Gilroy, N.; MacIntyre, R.; Gottlieb, D.; Ritchie, D.; Harrison, S.; Kennedy, G.; Watson, A.M.; Greenwood, M.; Doocey, R.; Perera, T.; Spencer, A.; Wong, E.; O'Brien, T.; Shaw, P.; Conyers, R.; Milliken, S.; Bardy, P.; Larsen, S.; Ho, P.J.; Lai, H.; Bajel, A.; Butler, J.; D'Rozario, J.; Johnston, A.; Cochrane, T.; Mills, T.; Irving, I.; Pullon, H.; Purtill, D. |
| 45 | | 30-May-2022 | Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia | Odutola, Michael K; van Leeuwen, Marina T; Turner, Jennifer; Bruinsma, Fiona; Seymour, John F; Prince, Henry M; Milliken, Samuel T; Trotman, Judith; Verner, Emma; Tiley, Campbell ; Roncolato, Fernando; Underhill, Craig R; Opat, Stephen S; Harvey, Michael; Hertzberg, Mark; Benke, Geza; Giles, Graham G; Vajdic, Claire M |
| 46 | | 30-Dec-2022 | Acute myeloid leukaemia with NPM1 mutation: no longer having an absolute blast (count) | Zhang, Lucy ; Campion, Victoria; Dickson, Michelle; Tang, Catherine |
